A New Insertion Technique for Laryngeal Mask Airway
1 other identifier
interventional
450
1 country
1
Brief Summary
A laryngeal mask airway ("LMA") is an airway device that is commonly used and placed under general anesthesia to facilitate ventilation of the patient's lungs while anesthetized. It is similar to an "endotracheal tube" (a breathing tube) but is less invasive. It is also placed as a backup when the Anesthesiologist is unable to pass a breathing tube and the patient is not adequately ventilating. Unfortunately, an LMA may lead to complications similar to those of breathing tube placement, such as sore throat and hoarse voice. Previous studies have examined several variables that may affect how often complications occur; these variables include giving anti-inflammatory medications and inflating the LMA to different pressures (the "working" end of the LMA, which rests in the patient's throat, has a cuff that is inflated to provide a seal). We are studying the effect of the PLACEMENT TECHNIQUE on postoperative sore throat, hoarse voice, and difficulty swallowing. We will be using 3 placement techniques - the traditional placement technique, a slightly different traditional placement technique, and a new technique, abbreviated the "ELLIA" method. The hypothesis of this study is that a new LMA insertion technique will have no difference in postoperative pharyngolaryngeal morbidity including sore throat, dysphagia and dysphonia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 11, 2012
CompletedFirst Posted
Study publicly available on registry
December 13, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedResults Posted
Study results publicly available
December 17, 2019
CompletedDecember 17, 2019
December 1, 2019
4.1 years
December 11, 2012
April 16, 2017
December 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Number of Subjects Who Present With Postoperative Sore Throat
The primary outcomes for this study will be postoperative pharyngolaryngeal complications of sore throat as reported by the participant.
24 hours
The Primary Outcomes for This Study Will be Postoperative Pharyngolaryngeal Complications Including Dysphonia
The primary outcomes for this study will be postoperative pharyngolaryngeal complications including dysphonia. Difficulty in speaking as assessed by the study team and reported by the participant 24 hours after LMA airway placement.
24 hours
The Primary Outcomes for This Study Will be Postoperative Dysphagia.
The primary outcomes for this study will be postoperative pharyngolaryngeal complication of dysphagia 24 hours after airway placement. This is assessed by a study team member during the 24 hour follow up or reported by the participant.
24 hours
The Primary Outcomes for This Study Will be Postoperative Pharyngolaryngeal Complications Including Dysphagia, Sore Throat and Dysphonia.
The primary outcomes for this study will be postoperative pharyngolaryngeal complications including dysphagia, sore throat and dysphonia 24 hours after airway placement.
24 hours
Secondary Outcomes (2)
Severity of Sore Throat
24 hours
Blood on LMA After Removal
Immediately after LMA removal
Study Arms (3)
Group 1 classic
ACTIVE COMPARATORGroup 1 Using the classic inserting technique and completely deflated LMA (Laryngeal Mask Airway)recommended in the LMA manual.
Group 2 pre inflated
ACTIVE COMPARATORGroup 2 (pre-inflated): Using the recommended inserting technique with the pre-inflated volume that exists in a LMA (Laryngeal Mask Airway) from the manufacturer
Group 3 ELL-PIC technique
ACTIVE COMPARATORGroup 3 (ELL-PIC): Using the ELL-PIC technique.
Interventions
Active Comparator: Group 1 classic Group 1 Using the classic inserting technique and completely deflated LMA recommended in the LMA manual.
Group 2 (pre-inflated): Using the recommended inserting technique with the pre-inflated volume that exists in a LMA (Laryngeal Mask Airway) from the manufacturer.
Eligibility Criteria
You may qualify if:
- ASA (American Society of Anesthesiologists patient fitness category) I, II, III
- Age 18-90
- General anesthetic for where LMA (Laryngeal Mask Airway) placement is not contraindicated will be included
You may not qualify if:
- Small mouth opening
- Preoperative sore throat/dysphagia/dysphonia
- Patients at increased risk for aspiration
- Morbid obesity BMI \> 40
- Untreated chronic GERD
- Pregnancy
- Suspected supraglottic abnormalities
- N2O use
- Need for oral-pharyngeal suctioning
- Undergoing oral and nasal surgery
- Intubation or any oral instrumental manipulations other than
- LMA placements intraoperatively or postoperatively
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Related Publications (1)
Hu LQ, Leavitt OS, Malwitz C, Kim H, Doty RA Jr, McCarthy RJ. Comparison of laryngeal mask airway insertion methods, including the external larynx lift with pre-inflated cuff, on postoperative pharyngolaryngeal complications: A randomised clinical trial. Eur J Anaesthesiol. 2017 Jul;34(7):448-455. doi: 10.1097/EJA.0000000000000650.
PMID: 28590309DERIVED
Limitations and Caveats
We did not limit the intracuff pressure of the device, but rather used the manufactures recommended volume in the cuff. . There are no current standard of care guidelines for the ideal intracuff pressures within the oropharngolaryngeal mask airway.
Results Point of Contact
- Title
- Ling Hu M.D.
- Organization
- Northwerstern University
Study Officials
- STUDY DIRECTOR
David Walega, MD
Northwestern University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 11, 2012
First Posted
December 13, 2012
Study Start
November 1, 2011
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
December 17, 2019
Results First Posted
December 17, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share